Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Tschöp

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Peptides|September 7, 2011
Ghrelin acylation and metabolic controlO Al Massadi, M H Tschöp, J Tong
Der Internist|July 27, 2019
[Incretin-based co- and tri-agonists : Innovative polypharmacology for the treatment of obesity and diabetes]A Harger, K Stemmer, M H Tschöp, et al.
The European Journal of Neuroscience|July 21, 2009
An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balanceJ Kampe, M H Tschöp, J H Hollis, et al.
The Journal of Endocrinology|June 1, 2018
Are peptide conjugates the golden therapy against obesity?S J Brandt, M Kleinert, M H Tschöp, et al.
Journal of Neuroendocrinology|May 9, 2008
The endocannabinoid system and the control of glucose homeostasisR Nogueiras, F Rohner-Jeanrenaud, S C Woods, et al.
Frontiers in Neuroendocrinology|November 10, 2009
Ghrelin in the regulation of body weight and metabolismT R Castañeda, J Tong, R Datta, et al.
Pharmacological Reviews|August 9, 2018
Anti-Obesity Therapy: from Rainbow Pills to PolyagonistsT D Müller, C Clemmensen, B Finan, et al.
Physiological Reviews|March 10, 2017
The New Biology and Pharmacology of GlucagonT D Müller, B Finan, C Clemmensen, et al.
Journal of Internal Medicine|September 20, 2018
Peptide-based multi-agonists: a new paradigm in metabolic pharmacologyS J Brandt, T D Müller, R D DiMarchi, et al.
Appetite|December 13, 2006
Peptide YY release in anorectic patients after liquid mealB Otto, U Cuntz, C Otto, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Peptides|September 7, 2011
Ghrelin acylation and metabolic controlO Al Massadi, M H Tschöp, J Tong
Der Internist|July 27, 2019
[Incretin-based co- and tri-agonists : Innovative polypharmacology for the treatment of obesity and diabetes]A Harger, K Stemmer, M H Tschöp, et al.
The European Journal of Neuroscience|July 21, 2009
An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balanceJ Kampe, M H Tschöp, J H Hollis, et al.
The Journal of Endocrinology|June 1, 2018
Are peptide conjugates the golden therapy against obesity?S J Brandt, M Kleinert, M H Tschöp, et al.
Journal of Neuroendocrinology|May 9, 2008
The endocannabinoid system and the control of glucose homeostasisR Nogueiras, F Rohner-Jeanrenaud, S C Woods, et al.
Frontiers in Neuroendocrinology|November 10, 2009
Ghrelin in the regulation of body weight and metabolismT R Castañeda, J Tong, R Datta, et al.
Pharmacological Reviews|August 9, 2018
Anti-Obesity Therapy: from Rainbow Pills to PolyagonistsT D Müller, C Clemmensen, B Finan, et al.
Physiological Reviews|March 10, 2017
The New Biology and Pharmacology of GlucagonT D Müller, B Finan, C Clemmensen, et al.
Journal of Internal Medicine|September 20, 2018
Peptide-based multi-agonists: a new paradigm in metabolic pharmacologyS J Brandt, T D Müller, R D DiMarchi, et al.
Appetite|December 13, 2006
Peptide YY release in anorectic patients after liquid mealB Otto, U Cuntz, C Otto, et al.
Pageof 3